Support Your Metabolism with Clinically-Studied Ingredients

Mitolyn — 6 plant-based nutrients to boost mitochondrial health, energy & natural fat burning.

★★★★★ 127,000+ customers · 90-day money-back guarantee

Dr. Lawrence Lynn, DO

Specialist Columbus, OH Male

NPI: 1861486276

Total Payments

$16.3M

2019 Payments

$5.2M

Companies

Transactions

Payment Breakdown by Category

Royalty/License$16.3M (100.0%)

Payments by Nature

Nature of Payment	Amount	Transactions	Share
Royalty or License	$16.3M	24	100.0%

Top Paying Companies

Company	Total	Records	Latest Year
Becton, Dickinson and Company	$15.2M	12	$0 (2019)
Covidien LP	$1.1M	12	$0 (2019)

Payment History by Year

Year	Amount	Transactions	Top Company
2019	$5.2M	8	Becton, Dickinson and Company ($4.8M)
2018	$5.7M	8	Becton, Dickinson and Company ($5.4M)
2017	$5.4M	8	Becton, Dickinson and Company ($5.0M)

All Payment Transactions

24 individual payment records from CMS Open Payments

Date	Company	Product	Nature	Form	Amount	Type
11/15/2019	Becton, Dickinson and Company	BD NEXIVA (Device), BD Q-SYTE	Royalty or License	Cash or cash equivalent	$668,531.00	General
Category: MEDICAL SURGICAL IV ACCESS
11/01/2019	Covidien LP	Nellcor (Device)	Royalty or License	Cash or cash equivalent	$107,380.00	General
Category: Pulse Oximetry
08/21/2019	Becton, Dickinson and Company	—	Royalty or License	Cash or cash equivalent	$1,452,409.00	General
08/02/2019	Covidien LP	Nellcor (Device)	Royalty or License	Cash or cash equivalent	$118,300.00	General
Category: Pulse Oximetry
05/28/2019	Becton, Dickinson and Company	BD NEXIVA (Device), BD Q-SYTE	Royalty or License	Cash or cash equivalent	$1,288,742.00	General
Category: MEDICAL SURGICAL IV ACCESS
04/30/2019	Covidien LP	Nellcor (Device)	Royalty or License	Cash or cash equivalent	$75,220.00	General
Category: Pulse Oximetry
02/18/2019	Becton, Dickinson and Company	BD NEXIVA (Device), BD Q-SYTE	Royalty or License	Cash or cash equivalent	$1,363,496.00	General
Category: MEDICAL SURGICAL IV ACCESS
01/18/2019	Covidien LP	Nellcor (Device)	Royalty or License	Cash or cash equivalent	$83,700.00	General
Category: Pulse Oximetry
11/09/2018	Becton, Dickinson and Company	BD Nexiva (Device), BD Q-Syte	Royalty or License	Cash or cash equivalent	$1,457,871.00	General
Category: Medical Surgical IV Access
10/29/2018	COVIDIEN LP	NELLCOR (Device)	Royalty or License	Cash or cash equivalent	$90,000.00	General
Category: PATIENT MONITORING
09/05/2018	Becton, Dickinson and Company	BD Nexiva (Device), BD Q-Syte	Royalty or License	Cash or cash equivalent	$1,370,723.00	General
Category: Medical Surgical IV Access
07/20/2018	COVIDIEN LP	NELLCOR (Device)	Royalty or License	Cash or cash equivalent	$83,700.00	General
Category: PATIENT MONITORING
05/15/2018	Becton, Dickinson and Company	BD Nexiva (Device), BD Q-Syte	Royalty or License	Cash or cash equivalent	$1,284,260.00	General
Category: Medical Surgical IV Access
04/20/2018	COVIDIEN LP	NELLCOR (Device)	Royalty or License	Cash or cash equivalent	$79,520.00	General
Category: PATIENT MONITORING
02/09/2018	COVIDIEN LP	NELLCOR (Device)	Royalty or License	Cash or cash equivalent	$85,220.00	General
Category: PATIENT MONITORING
02/07/2018	Becton, Dickinson and Company	BD Nexiva (Device), BD Q-Syte	Royalty or License	Cash or cash equivalent	$1,281,778.00	General
Category: Medical Surgical IV Access
11/10/2017	Becton, Dickinson and Company	BD Nexiva (Device), BD Q-Syte	Royalty or License	Cash or cash equivalent	$1,343,108.00	General
Category: Medical Surgical IV Access
10/20/2017	Covidien LP	Nellcor (Device)	Royalty or License	Cash or cash equivalent	$99,280.00	General
Category: Patient Monitoring
08/08/2017	Becton, Dickinson and Company	BD Nexiva (Device), BD Q-Syte	Royalty or License	Cash or cash equivalent	$1,241,435.00	General
Category: Medical Surgical IV Access
07/21/2017	Covidien LP	Nellcor (Device)	Royalty or License	Cash or cash equivalent	$92,860.00	General
Category: Patient Monitoring
05/23/2017	Becton, Dickinson and Company	BD Nexiva (Device), BD Q-Syte	Royalty or License	Cash or cash equivalent	$1,226,990.00	General
Category: Medical Surgical IV Access
05/01/2017	Covidien LP	Nellcor (Device)	Royalty or License	Cash or cash equivalent	$105,780.00	General
Category: Patient Monitoring
03/02/2017	Becton, Dickinson and Company	BD Nexiva (Device), BD Q-Syte	Royalty or License	Cash or cash equivalent	$1,212,212.00	General
Category: Medical Surgical IV Access
01/30/2017	Covidien LP	Nellcor (Device)	Royalty or License	Cash or cash equivalent	$95,740.00	General
Category: Patient Monitoring

About Dr. Lawrence Lynn, DO

Dr. Lawrence Lynn, DO is a Specialist healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861486276.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Lynn, DO has received a total of $16.3M in payments from pharmaceutical and medical device companies, with $5.2M received in 2019. These payments were reported across 24 transactions from 2 companies. The most common payment nature is "Royalty or License" ($16.3M).

16,000 Woodworking Plans

Step-by-step blueprints for any project. Beginner to expert.

Detailed schematics Cutting lists & materials Lifetime access — $67

★★★★★ 60-day guarantee

Get Instant Access

Practice Information

Specialty Specialist
Location Columbus, OH
Active Since 08/31/2005
Last Updated 08/10/2015
Taxonomy Code 174400000X
Entity Type Individual
NPI Number 1861486276

Products in Payments

BD Nexiva (Device) $10.4M
BD NEXIVA (Device) $3.3M
Nellcor (Device) $778,260
NELLCOR (Device) $338,440

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.